Acute Endothelin-A Receptor Antagonism Prevents Normal Reduction of Myocardial Ischemia on Repeated Balloon Inflations During Angioplasty

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Circulation

• Publication date

  2000-10-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.102.16.1937PMID 11034942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenous endothelin maintains coronary artery tone by endothelin type A receptor stimulation in patients undergoing coronary arteriography

  2000cited by this paper
• Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men.

  1999cited by this paper
• Hemodynamic and coronary effects of the endothelin antagonist bosentan in patients with coronary artery disease.

  1998cited by this paper
• Systemic and renal effects of an ETA receptor subtype‐specific antagonist in healthy subjects

  1998cited by this paper
• Validation of Fractional Flow Reserve in Animals

  1997cited by this paper
• Phentolamine prevents adaptation to ischemia during coronary angioplasty: role of alpha-adrenergic receptors in ischemic preconditioning.

  1997cited by this paper
• Endothelin-1 and myocardial preconditioning.

  1996cited by this paper
• Dose-dependent effect of endothelin-1 on blood flow to normal and collateral-dependent myocardium.

  1996cited by this paper
• Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart.

  1996cited by this paper
• Vein plasma endothelin-1 and cyclic GMP increase during coronary angioplasty is related to myocardial ischaemia.

  1995cited by this paper
• The reactivity of the contralateral artery at the time of balloon dilation during coronary angioplasty.

  1995cited by this paper
• Tissue endothelin-1 levels in perfused rat heart following stimulation with agonists and in ischaemia and reperfusion.

  1995cited by this paper
• Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig.

  1995cited by this paper
• The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion

  1994cited by this paper
• Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: studies with bosentan, a mixed ETA‐ETB antagonist

  1994cited by this paper
• Contribution of endogenous generation of endothelin-1 to basal vascular tone.

  1994cited by this paper
• Intravenous administration of the endothelin-1 antagonist BQ-123 does not ameliorate myocardial ischaemic injury following acute coronary artery occlusion in the dog.

  1994cited by this paper
• Effects of Endothelin‐1 at Pathophysiologic Concentrations on Coronary Perfusion and Mechanical Function of Normal and Postischemic Myocardium

  1994cited by this paper
• The endothelin family of peptides: local hormones with diverse roles in health and disease?

  1993cited by this paper
• The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion.

  1993cited by this paper
• Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.

  1992cited by this paper
• Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study.

  1992cited by this paper
• Contribution of endogenous endothelin to the extension of myocardial infarct size in rats.

  1991cited by this paper
• Ischemia and reperfusion increase 125I-labeled endothelin-1 binding in rat cardiac membranes.

  1990cited by this paper
• Balloon occlusion during coronary angioplasty as a model of myocardial ischaemia: reproducibility of sequential inflations.

  1989cited by this paper
• The measurement of pain.

  1988cited by this paper
• Value of the intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous transluminal coronary angioplasty.

  1986cited by this paper
• Measurement of pain.

  1974cited by this paper

• Endothelin: 30 Years From Discovery to Therapy.

  2019cites this paper
• Experimental and early investigational drugs for angina pectoris

  2016cites this paper
• Assessment of Circulatory Levels of Endothelin-1 in Diabetic Subjects Screened Through a Cross Sectional Study from Rural Women in Bangladesh

  2015cites this paper
• New Antianginal Drugs Still Not Available for Clinical Use

  2015cites this paper
• Endothelin A-receptors and the coronary circulation

  2013cites this paper
• The intracoronary electrocardiogram in percutaneous coronary intervention.

  2009cites this paper
• Chronic stable angina pectoris.

  2008cites this paper
• Repeated Balloon Inflations Do Not Diminish ST Segment Elevation even though Coronary Collateral Recruitment Is Promoted in Pigs

  2007cites this paper
• P reconditioning Effect during Coronary Angioplasty in Patients with Stable Angina Pectoris Kenya

  2007cites this paper
• Differential effects of protein kinase C isoform activation in endothelin-mediated myocyte contractile dysfunction with cardioplegic arrest and reperfusion.

  2006cites this paper
• Endothelin receptor--a blockade decreases ventricular arrhythmias after myocardial infarction in rats.

  2005cites this paper
• Treatment of refractory angina pectoris.

  2005cites this paper
• [Reduced coronary collateral vessel recruitment capacity in diabetes mellitus: an evidence for defective ischaemic tolerance].

  2004cites this paper
• The endothelin system and its role in acute myocardial infarction

  2004influential citation
• Endothelial dysfunction in atherosclerosis.

  2003cites this paper
• Usefulness of endothelin(A) receptor antagonists for the prevention of in-stent restenosis in patients with stable angina pectoris or silent myocardial ischemia.

  2003cites this paper
• Usefulness of endothelinA receptor antagonists for the prevention of in-stent restenosis in patients with stable angina pectoris or silent myocardial ischemia

  2003cites this paper
• Electrophysiologic Effects of Endothelin Receptor–A Blockade in Patients with Coronary Artery Disease

  2003cites this paper
• Type II diabetes does not prevent the recruitment of collateral vessels and the normal reduction of myocardial ischaemia on repeated balloon inflations during angioplasty

  2002cites this paper
• Hyperlipidemia prevents the expected reduction of myocardial ischemia on repeated balloon inflations during angioplasty.

  2002cites this paper
• Preconditioning effect during coronary angioplasty in patients with stable angina pectoris.

  2002cites this paper
• Role of endothelin in cardiovascular disease

  2002cites this paper
• Role of endothelin in cardiovascular disease

  2002cites this paper
• Nicorandil enhances myocardial tolerance to ischemia without progressive collateral recruitment during coronary angioplasty.

  2002cites this paper
• Endothelin antagonists for chronic heart failure: do they have a role?

  2001cites this paper
• Coronary vasoconstriction after coronary angioplasty is attenuated by endothelin a receptor antagonism.

  2001cites this paper
• Functions of the healthy endothelium.

  2001cites this paper
• Role of endogenous endothelin on coronary flow in health and disease

  2001cites this paper